← Back to all trials
Not Yet Recruiting
NCT05750056
Dose Systemic Lidocaine Improve the Quality of Recovery After Colorectal Endoscopic Submucosal Dissection
Conditions: Postoperative Recovery
Sex: All
Ages: 18 Years – N/A
Phase: PHASE4
Enrollment: 234
Sponsor: Fujian Provincial Hospital
Location: China
Summary
Endoscopic submucosal dissection (ESD) is a common procedure that requires a long procedural time.
Procedure Sedation is commonly provided to alleviate patients' discomfort and facilitate the implementation of procedures.
We conducted a prospective study to determine the effect of intravenous infusion of lidocaine in the cognitive domain of the postoperative quality of recovery scale on day 3 after ESD.
Eligibility Criteria
Inclusion Criteria:American Society of Anesthesiologists (ASA) classification I-III;Scheduled for endoscopic colorectal mucosal dissection.Exclusion Criteria:Patient refuses to participate;BMI greater than 30;Allergic or contraindication to study drugs;History of chronic pain and long-term use of analgesic medication;Severe arrhythmia;Hepatic and renal dysfunction;Any other conditions precluded study inclusion, such as cognitive impairment, pregnancy, or inability to communicate in Mandarin Chinese.
Source: ClinicalTrials.gov (NCT05750056). StuddyBuddy aggregates publicly available trial information.